Video
Author(s):
In this video, Brian D. Gonzalez, PhD, discusses the background, findings, and takeaways of the study, “Improvements in symptoms related to bone metastasis in recipients of Lutetium-177 PSMA-617 for prostate cancer,” which was presented at the 2022 ASCO Genitourinary Cancers Symposium. Gonzalez is an associate member and quality of life researcher at Moffitt Cancer Center in Tampa, Florida.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
2 Commerce Drive
Cranbury, NJ 08512